companydata.dkcompanydata.dk

Hoba Therapeutics ApS: Financial statements 2022

CVR: 38231170

Source: annual report 2022, Danish Business Authority

01/04/2021 – 31/03/2022

Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,181,695 and a net result of DKK -10,898,671 compared with DKK -1,944,679 the year before. Equity in the 2022 report amounted to DKK -18,974,916. The company had 3 employees in the financial year.

Revenue
DKK 0
Gross Profit
DKK -7,181,695
Profit/Loss
DKK -10,898,671
Equity
DKK -18,974,916
Total Assets
DKK 19,646,302
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20220-7.2M-10.9M-19M3
2021-1.4M-1.9M8.2M3
2020-839K-1.6M10.1M2
2019-296K-1.1M11.7M-
2018-485K-892K8.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Hoba Therapeutics ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Hoba Therapeutics ApS appoints new auditorJun 28, 2022

As of June 28, 2022, EY Godkendt Revisionspartnerselskab has been appointed auditor of Hoba Therapeutics ApS.

Auditor steps down at Hoba Therapeutics ApSJun 28, 2022

As of June 28, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Hoba Therapeutics ApS.

Lene Gerlach joins the board of Hoba Therapeutics ApSJun 28, 2022

As of June 28, 2022, Lene Gerlach has joined the board of directors of Hoba Therapeutics ApS.

Thor Jespersen leaves the board of Hoba Therapeutics ApSJun 28, 2022

As of June 28, 2022, Thor Jespersen has left the board of directors of Hoba Therapeutics ApS.

About Hoba Therapeutics ApS

Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.

Source: annual report 2026, Danish Business Authority